| Phase 3 |
| NCT05929222 |
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage… |
Follicular Lymphoma |
Recruiting |
2026-09-08 |
| NCT07256158 |
PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable… |
Hodgkin Lymphoma |
Recruiting |
2026-08-27 |
| NCT04442412 |
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by… |
Diffuse Large B-Cell Lymphoma |
Recruiting |
2022-08-26 |
| NCT02390869 |
Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for… |
Lymphoma, Follicular |
Active, Not Recruiting |
2026-08-19 |
| NCT05058404 |
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment… |
Follicular Lymphoma |
Active, Not Recruiting |
2026-06-26 |
| Phase 2 |
| NCT04915248 |
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL… |
Plasmablastic Lymphoma |
Recruiting |
2026-09-09 |
| NCT06835530 |
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients… |
Diffuse Large B Cell Non-Hodgkin Lymphoma |
Recruiting |
2026-08-24 |
| NCT05977673 |
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma… |
Hodgkin Lymphoma |
Recruiting |
2026-08-19 |
| NCT07453095 |
Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following… |
Mantle Cell Lymphoma |
Recruiting |
2026-06-25 |
| NCT06492837 |
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients |
Follicular Lymphoma |
Active, Not Recruiting |
2026-09-11 |
| NCT03731234 |
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance |
DLBCL |
Active, Not Recruiting |
2026-09-08 |
| NCT05249959 |
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in… |
Relapsed Mantle Cell Lymphoma |
Active, Not Recruiting |
2026-08-24 |
| NCT07207785 |
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell… |
Mantle Cell Lymphoma |
Not Yet Recruiting |
2025-10-06 |
| Phase 1/2 |
| NCT05300282 |
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma… |
Relapsed or Refractory Hodgkin's Lymphoma |
Active, Not Recruiting |
2026-09-11 |
| Not applicable |
| NCT05934084 |
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors |
Classical Hodgkin Lymphoma |
Recruiting |
2026-09-11 |
| NCT07476105 |
Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With… |
Diffuse Large B Cell Lymphoma |
Not Yet Recruiting |
2026-04-15 |
| Not specified |
| NCT05524298 |
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma |
Low Grade Non-Hodgkin's Lymphoma, Adult |
Recruiting |
2026-09-11 |
| NCT05819528 |
Primary Cardiac Lymphoma: Italian Multicenter Experience |
Primary Cardiac Lymphoma |
Recruiting |
2026-08-24 |
| NCT06781359 |
Study on Plasmablastic Lymphoma Patients |
Plasmablastic Lymphoma |
Recruiting |
2026-08-19 |
| NCT05816850 |
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational… |
Follicular Lymphoma |
Recruiting |
2025-12-29 |
| NCT06008691 |
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal… |
Non-Hodgkin Lymphoma, B-cell |
Recruiting |
2025-12-29 |
| NCT06588205 |
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With… |
Diffuse Large B Cell Lymphoma |
Recruiting |
2025-12-29 |
| NCT06156774 |
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell… |
Non-hodgkin Lymphoma,B Cell |
Recruiting |
2025-12-08 |
| NCT06588868 |
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma |
Cutaneous T Cell Lymphoma |
Recruiting |
2025-12-02 |
| NCT07467317 |
BV-CHP Real-life and Biological Evidences in Patients With sALCL |
Anaplastic Large Cell Lymphoma |
Not Yet Recruiting |
2026-09-09 |